Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Angel & family office | 1 | 17% |
| Bank & private debt | 2 | 33% |
| Other / undisclosed | 1 | 17% |
Developer of therapeutics for the treatment of neurological diseases
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Angel & family office | 1 | 17% |
| Bank & private debt | 2 | 33% |
| Other / undisclosed | 1 | 17% |